Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)

Cervical cancer is ranked fourth among the top cancers in women and is the second most common cancer in low- and middle-income regions, with ~570,000 new cases reported in 2018, which attributed to 84% of worldwide cervical cancer cases. Three commercially available prophylactic Human papillomavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Naupu, Paulina N., van Zyl, Albertha R., Rybicki, Edward P., Hitzeroth, Inga I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762164/
https://www.ncbi.nlm.nih.gov/pubmed/33291259
http://dx.doi.org/10.3390/vaccines8040740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762164/
https://www.ncbi.nlm.nih.gov/pubmed/33291259
http://dx.doi.org/10.3390/vaccines8040740

Ejemplares similares